Skip to content

Raltegravir may have role in PEP if exposure involves drug-resistant HIV

IL-2 provides quick ‘AIDS rescue’, but effect does not always last

Second-line combinations fail twice as often as first-line ones in the first year

Once-a-day etravirine should work as first-line treatment

One in five Kenyan patients suffers major interactions between HIV drugs and other medicines

If you can't switch, better to stay on failing treatment than stop it, studies show

Non-nucleoside resistance is efficiently transmitted within infection ‘clusters’

One in five Kenyan patients suffers major interactions with HIV drugs

South African resistance survey confirms that clade C is more likely to develop multi-drug resistance mutation